Stay updated on Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial
Sign up to get notified when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.

Latest updates to the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page
- CheckyesterdayChange DetectedThe page’s release/version label was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedTexas location listing updated from UT Health San Antonio to The University of Texas Health Science Center at San Antonio.SummaryDifference0.1%

- Check30 days agoChange Detected- Revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed on the page.SummaryDifference0.1%

- Check51 days agoChange DetectedNo additions or deletions were detected; observed differences appear to be non-substantive layout or rendering changes rather than updates to core study details.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision label updates from v3.4.1 to v3.4.2; This is a minor maintenance change that does not alter study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.